WeedPress Proved Harvard Law Review Wrong: The Controlled Substances Act Is an Architecture of Exemptions — and History Just Proved It

For nearly two decades WeedPress has argued that the Controlled Substances Act is not a rigid prohibition statute but an architecture of exemptions — a flexible regulatory framework deliberately designed to allow medical, research, and other carve-outs while maintaining federal control.¹ A recent Harvard Law Review article largely missed this central feature of the statute.² That assessment has now been proven wrong this past month as Trump has approved federal exemption for state approved medical marijuana.

The exemption architecture argument was not fringe speculation. It was the correct reading of the statute’s text, structure, and history.³ In 2021, during the Trump administration, a U.S. ambassador to the International Narcotics Control Board reportedly aligned with this framework when the United States argued that exemptions and controlled carve-outs are central to how the CSA operates.⁴ That diplomatic position did not itself change federal law, but it foreshadowed the federal partial rescheduling shockwave of April 2026.⁵

WeedPress was there from the beginning, documenting the exemption pathway long before it became official policy.⁶ When the DEA issued its April 28, 2026 final order creating a Schedule III pathway for certain FDA-approved marijuana products and qualifying state-licensed medical cannabis, it vindicated twenty years of analysis.⁷ The Trump administration made the exemption official.⁸ The very mechanism WeedPress had been pioneering since the early 2010s is now federal law.⁹

No. 4 – The Controlled Substances Act Is Not a Blunt Instrument — It Is an Architecture of Exceptions

The downstream effects are already rippling through the states. South Carolina and at least twenty-six other states have automatic or mandatory conformity mechanisms that are now being triggered.¹⁰ Massachusetts and Arizona — two mature markets — are grappling with distinct conformity problems created by the federal shift.¹¹ West Virginia and Mississippi both attempted Schedule III bills that exposed the same structural gaps WeedPress had flagged years earlier.¹² South Dakota’s own Schedule I prohibition is now headed to court this summer precisely because the state’s statutory criteria for scheduling no longer align with federal reality.¹³

The Federal Rescheduling Shockwave Hits: South Carolina and 26 Other States Appear to Have Automatic or Mandatory Conformity Mechanisms for Federal Marijuana Scheduling Changes

These are not isolated state stories. They are the predictable consequences of the exemption architecture finally being activated at the federal level.¹⁴ The rescheduling shockwave is hitting every state with conformity language, forcing legislatures, regulators, and courts to confront the very dynamics WeedPress has mapped for two decades.¹⁵

As a policy specialist obsessed with federal and international drug-law exemptions, I noted with particular satisfaction when the 2021 U.S. position before the INCB foreshadowed the framework WeedPress had been advancing.¹⁶ That moment confirmed the analysis was not only correct but diplomatically actionable.¹⁷ The exemption pathway was always latent in the CSA; it simply required the right combination of administrative will and persistent advocacy to unlock.¹⁸

The Harvard Law Review scholarship treated the CSA primarily as a prohibition regime rather than the dynamic exemption engine it was designed to be.¹⁹ History has now corrected the record.²⁰ The federal rescheduling order of April 2026 is the clearest proof yet that the architecture of exemptions was the right lens all along.²¹

WeedPress will continue tracking the state-level conformity battles that the federal move has unleashed.²² The exemption framework is no longer theoretical — it is operational policy.²³ Patients, small operators, and regulators deserve clear, real-time analysis of what comes next.²⁴ The public record must reflect the full arc: two decades of advocacy, a pivotal 2021 diplomatic acknowledgment, and the 2026 federal breakthrough that finally made the exemption architecture official.²⁵

This breakthrough rests on long-standing statutory authority under the CSA.²⁶ It also triggers procedural steps that WeedPress has already engaged through formal participation in the ongoing administrative process.²⁷ South Dakota’s medical cannabis program, born of citizen initiative, now sits at the center of this national realignment.²⁸ The broader rescheduling hearing scheduled for June 29, 2026, will test how far the exemption architecture can extend.²⁹

**WeedPress will continue documenting that policy vacuum as the June hearing approaches.**³⁰

South Dakota’s Schedule I Marijuana Prohibition Heads to Court This Summer: Lawsuit Will Seek Declaration That State Law No Longer Satisfies Its Own Criteria

Footnotes

¹ Jason Karimi, The Controlled Substances Act as Architecture of Exemptions: WeedPress https://weedpress.org/2026/02/13/the-controlled-substances-act-is-not-a-blunt-instrument-it-is-an-architecture-of-exceptions/

² Matthew B. Lawrence & David E. Pozen, Drug Scheduling as Institutional Design, 139 Harv. L. Rev. 849 (2026), https://harvardlawreview.org/wp-content/uploads/2026/02/139-Harv.-L.-Rev.-849.pdf.

³ 21 U.S.C. § 801 et seq. (Controlled Substances Act).

⁴ See Marijuana Moment reporting cited by U.S. delegation to the International Narcotics Control Board (2021).

⁵ Schedules of Controlled Substances: Rescheduling of Food and Drug Administration Approved Products Containing Marijuana From Schedule I to Schedule III; Corresponding Change to Permit Requirements, 91 Fed. Reg. 22714 (Apr. 28, 2026) (2026-08176), https://www.federalregister.gov/documents/2026/04/28/2026-08176.

⁶ Jason Karimi, WeedPress Policy Series on CSA Exemptions (supra note 1).

⁷ 91 Fed. Reg. 22714 (Apr. 28, 2026).

⁸ Id.

⁹ Id.

¹⁰ Jason Karimi, The Federal Rescheduling Shockwave Hits South Carolina and 26 Other States Appear to Have Automatic or Mandatory Conformity Mechanisms for Federal Marijuana Scheduling Changes, WeedPress (May 5, 2026), https://weedpress.org/2026/05/05/the-federal-rescheduling-shockwave-hits-south-carolina-and-26-other-states.

¹¹ Jason Karimi, Massachusetts and Arizona After the Partial Federal Schedule III Shift: Two Mature Markets, Two Different Conformity Problems, WeedPress (May 4, 2026), https://weedpress.org/2026/05/04/massachusetts-and-arizona-after-the-partial-federal-schedule-iii-shift-two-mature-markets-two-different-conformity-problems.

¹² Jason Karimi, West Virginia and Mississippi Tried to Move Marijuana to Schedule III — Both Bills Reveal the Same Structural Problem, WeedPress (Apr. 24, 2026), https://weedpress.org/2026/04/24/west-virginia-and-mississippi-tried-to-move-marijuana-to-schedule-iii-both-bills-reveal-the-same-structural-problem.

¹³ Jason Karimi, South Dakota’s Schedule I Marijuana Prohibition Heads to Court This Summer — Lawsuit Will Seek Declaration That State Law No Longer Satisfies Its Own Criteria, WeedPress (Apr. 28, 2026), https://weedpress.org/2026/04/28/south-dakotas-schedule-i-marijuana-prohibition-heads-to-court-this-summer-lawsuit-will-seek-declaration-that-state-law-no-longer-satisfies-its-own-criteria.

¹⁴ See supra notes 10–13.

¹⁵ Jason Karimi, I Spent 17 Years Arguing for Federal Cannabis Legitimacy — Now Small Operators Are About to Learn What That Means, WeedPress (May 9, 2026), https://weedpress.org/2026/05/09/i-spent-17-years-arguing-for-federal-cannabis-legitimacy-now-small-operators-are-about-to-learn-what-that-means.

¹⁶ See Marijuana Moment

¹⁷ Id.

¹⁸ 21 U.S.C. § 801 et seq. (Controlled Substances Act).

¹⁹ Lawrence & Pozen, supra note 2, at 856–62.

²⁰ 91 Fed. Reg. 22714 (Apr. 28, 2026).

²¹ Id.

²² See supra notes 10–13.

²³ Jason Karimi, I Have Filed Notice to Participate in the DEA’s June 29 Rescheduling Hearing, WeedPress (May 10, 2026), https://weedpress.org/2026/05/10/i-have-filed-notice-to-participate-in-the-deas-june-29-rescheduling-hearing.

²⁴ Jason Karimi, WeedPress Exclusive: WeedPress Founder & Veteran Cannabis Advocate Jason Karimi Tapped as Expert Witness in Federal Religious Cannabis Lawsuits — Ready to Testify This Summer, WeedPress (May 8, 2026), https://weedpress.org/2026/05/08/weedpress-exclusive-weedpress-founder-veteran-cannabis-advocate-jason-karimi-tapped-as-expert-witness-in-federal-religious-cannabis-lawsuits-ready-to-testify-this-summer.

²⁵ See supra notes 1, 6, 15.

²⁶ 21 U.S.C. § 823 (DEA registration authority); see also 21 U.S.C. § 811(d)(1) (treaty obligations and scheduling authority).

²⁷ Jason Karimi, I Have Filed Notice to Participate in the DEA’s June 29 Rescheduling Hearing, WeedPress (May 10, 2026), https://weedpress.org/2026/05/10/i-have-filed-notice-to-participate-in-the-deas-june-29-rescheduling-hearing.

²⁸ South Dakota Initiated Measure 26 (2020).

²⁹ DEA Docket No. DEA-1362, Schedules of Controlled Substances: Rescheduling of Marijuana, 91 Fed. Reg. 22777 (Apr. 28, 2026) (hearing begins June 29, 2026; notices due May 28, 2026), https://www.federalregister.gov/documents/2026/04/28/2026-08177.

³⁰ Jason Karimi, The Policy Vacuum: What Happens When Leadership Steps Back During Federal Cannabis Rescheduling, WeedPress (May 13, 2026), https://weedpress.org/2026/05/13/the-policy-vacuum.